SEARCH RESULTS FOR:

Italy
Pharma & Life Sciences

Stefano Collatina

COUNTRY LEAD, BAXTER
Italy Life Sciences 2021
Baxter in Italy outlines its operations and outlook.
Italy
Pharma & Life Sciences

Vittorio Broccoli & Maud Saillard

EXPORT SALES EXECUTIVES, ERBOZETA
Italy Life Sciences 2021
Erbozeta explains how it maintains a high level of growth.
Mining
South Africa
MACIG

Cobus Loots

CEO, PAN AFRICAN RESOURCES
MACIG Southern Africa 2021 - Digital Interactive
Pan African Resources is a mid-tier African-focused gold producer listed in Johannesburg and on the AIM market in London.
Mining
South Africa
MACIG

Michael Stares & Scott Jobin-Bevans

PRESIDENT AND CEO & VICE PRESIDENT EXPLORATION, WHITE METAL RESOURCES
MACIG Southern Africa 2021 - Digital Interactive
White Metal Resources provides insights into its pipeline.
Mexico
Petrochemicals & Chemicals

Patricio Cueva

CEO, REACCIONES QUÍMICAS
Reacciones Químicas outlines opportunities in Mexico’s coatings segment.
Mining
Canada

Tom Obradovich

PRESIDENT AND CEO, CONQUEST RESOURCES
Conquest Resources updates GBR in its exploration projects on the Temagami Magnetic Anomaly.
Mining
Canada

Jake Klein

EXECUTIVE CHAIRMAN, EVOLUTION MINING
Evolution Mining updates GBR on progress at its gold assets in Ontario, Australia and West Africa.
Italy
Pharma & Life Sciences

Alessandro Casero

CEO, FARMAKA
Italy Life Sciences 2021
Farmaka describes its formulations that are ready to me marketed worldwide.
Mining
South Africa
MACIG

Gwede Mantashe

MINISTER OF MINERAL RESOURCES, DEPARTMENT OF MINERAL RESOURCES AND ENERGY, SOUTH AFRICA
MACIG Southern Africa 2021 - Digital Interactive
Gwede Mantashe, Minister of Mineral Resources and Energy for South Africa, explains efforts to revive the mining and power sectors.
Italy
Pharma & Life Sciences

Massimo Montironi

CEO, IDI FARMACEUTICI
Italy Life Sciences 2021
IDI Farmaceutici develops and produces products for the cure and treatment of skin conditions.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL